Literature DB >> 22654264

Hepatic transcatheter arterial chemoembolization complicated by postembolization syndrome.

Sabeen Dhand1, Ramona Gupta.   

Abstract

Postembolization syndrome (PES) is a common complication after embolic procedures, and it is a frequent cause of extended inpatient hospital admissions. PES is a self-limited constellation of symptoms consisting of fevers, unremitting nausea, general malaise, loss of appetite, and variable abdominal pain following the procedure. Although a definite cause is unknown, this syndrome is thought to be a result of therapeutic cytotoxicity, tumor ischemia, and resulting intrahepatic and extrahepatic inflammation. The authors report a case of PES precipitated by transcatheter intrarterial chemoembolization of hepatic metastases.

Entities:  

Keywords:  Postembolization syndrome (PES); chemoembolization; complications; embolization complications; hepatocellular carcinoma (HCC); transcatheter arterial chemoembolization (TACE)

Year:  2011        PMID: 22654264      PMCID: PMC3193324          DOI: 10.1055/s-0031-1280666

Source DB:  PubMed          Journal:  Semin Intervent Radiol        ISSN: 0739-9529            Impact factor:   1.513


  12 in total

1.  Hepatic arterial chemoembolization in the management of advanced digestive endocrine tumors.

Authors:  P Ruszniewski; D Malka
Journal:  Digestion       Date:  2000       Impact factor: 3.216

2.  Chemoembolization for hepatocellular carcinoma: comprehensive imaging and survival analysis in a 172-patient cohort.

Authors:  Robert J Lewandowski; Mary F Mulcahy; Laura M Kulik; Ahsun Riaz; Robert K Ryu; Talia B Baker; Saad M Ibrahim; Michael I Abecassis; Frank H Miller; Kent T Sato; Seanthan Senthilnathan; Scott A Resnick; Edward Wang; Ramona Gupta; Richard Chen; Steven B Newman; Howard B Chrisman; Albert A Nemcek; Robert L Vogelzang; Reed A Omary; Al B Benson; Riad Salem
Journal:  Radiology       Date:  2010-06       Impact factor: 11.105

3.  Complications associated with transcatheter arterial embolization for hepatic tumors.

Authors:  I Sakamoto; N Aso; K Nagaoki; Y Matsuoka; M Uetani; K Ashizawa; S Iwanaga; M Mori; M Morikawa; T Fukuda; K Hayashi; N Matsunaga
Journal:  Radiographics       Date:  1998 May-Jun       Impact factor: 5.333

4.  Regional anesthesia for hepatic arterial embolization.

Authors:  D M Coldwell; K A Loper
Journal:  Radiology       Date:  1989-09       Impact factor: 11.105

5.  Transarterial embolization for hepatocellular carcinoma. Antibiotic prophylaxis and clinical meaning of postembolization fever.

Authors:  A Castells; J Bruix; C Ayuso; C Brú; X Montanyà; L Boix; J Rodès
Journal:  J Hepatol       Date:  1995-04       Impact factor: 25.083

6.  Cytolysis following chemoembolization for hepatocellular carcinoma.

Authors:  F Paye; O Farges; M Dahmane; V Vilgrain; J F Flejou; J Belghiti
Journal:  Br J Surg       Date:  1999-02       Impact factor: 6.939

7.  Determinants of postembolization syndrome after hepatic chemoembolization.

Authors:  D A Leung; J E Goin; C Sickles; B J Raskay; M C Soulen
Journal:  J Vasc Interv Radiol       Date:  2001-03       Impact factor: 3.464

Review 8.  Transcatheter arterial chemoembolization for hepatocellular carcinoma: anatomic and hemodynamic considerations in the hepatic artery and portal vein.

Authors:  Kwang-Hun Lee; Kyu-Bo Sung; Do-Yun Lee; Sang Joon Park; Ki Whang Kim; Jeong-Sik Yu
Journal:  Radiographics       Date:  2002 Sep-Oct       Impact factor: 5.333

9.  Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group.

Authors:  Anja Rinke; Hans-Helge Müller; Carmen Schade-Brittinger; Klaus-Jochen Klose; Peter Barth; Matthias Wied; Christina Mayer; Behnaz Aminossadati; Ulrich-Frank Pape; Michael Bläker; Jan Harder; Christian Arnold; Thomas Gress; Rudolf Arnold
Journal:  J Clin Oncol       Date:  2009-08-24       Impact factor: 44.544

10.  Hepatic tumors: predisposing factors for complications of transcatheter oily chemoembolization.

Authors:  J W Chung; J H Park; J K Han; B I Choi; M C Han; H S Lee; C Y Kim
Journal:  Radiology       Date:  1996-01       Impact factor: 11.105

View more
  18 in total

1.  Prevention of post-embolization syndrome after transarterial chemoembolization for hepatocellular carcinoma-is prophylactic dexamethasone useful, or not?

Authors:  Toru Ishikawa
Journal:  Hepatobiliary Surg Nutr       Date:  2018-06       Impact factor: 7.293

Review 2.  Mental status changes postchemoembolization: the role of inflammatory response.

Authors:  Daniel Wells; Joseph Alisky; Charles E Ray
Journal:  Semin Intervent Radiol       Date:  2013-06       Impact factor: 1.513

3.  Solid pseudopapillary tumour (Frantz's tumour) of the pancreas in childhood: successful management of late liver metastases with sunitinib and chemoembolisation.

Authors:  Mauricio Antonio Escobar; John Mason McClellan; William Thomas
Journal:  BMJ Case Rep       Date:  2017-12-22

4.  Post-embolization syndrome as an early predictor of overall survival after transarterial chemoembolization for hepatocellular carcinoma.

Authors:  Meredith C Mason; Nader N Massarweh; Aitua Salami; Mark A Sultenfuss; Daniel A Anaya
Journal:  HPB (Oxford)       Date:  2015-09-16       Impact factor: 3.647

5.  Post-embolization neurological syndrome after embolization for intracranial and skull base tumors: transient exacerbation of neurological symptoms with inflammatory responses.

Authors:  Yujiro Tanaka; Takao Hashimoto; Daisuke Watanabe; Hirofumi Okada; Daichi Kato; Shigeru Aoyagi; Jiro Akimoto; Michihiro Kohno
Journal:  Neuroradiology       Date:  2018-06-18       Impact factor: 2.804

6.  Advances and Future Directions in the Treatment of Hepatocellular Carcinoma.

Authors:  Ashil J Gosalia; Paul Martin; Patricia D Jones
Journal:  Gastroenterol Hepatol (N Y)       Date:  2017-07

7.  Role of N-acetyl Cysteine in Post-transarterial Chemoembolization Transaminitis in Hepatocellular Carcinoma: A Single-center Experience.

Authors:  Chandan K Kedarisetty; Sipra Bal; Subhashree Parida; Mayank Jain; Ajeet S Bhadoria; Joy Varghese; Jayanthi Venkataraman
Journal:  J Clin Exp Hepatol       Date:  2020-10-27

8.  Pulmonary complications of transcatheter arterial chemoembolization for hepatocellular carcinoma.

Authors:  Quan M Nhu; Harry Knowles; Paul J Pockros; Catherine T Frenette
Journal:  World J Respirol       Date:  2016-11-28

9.  Comparison of transcatheter arterial chemoembolization with raltitrexed plus liposomal doxorubicin vs. tegafur plus pirarubicin for unresectable hepatocellular carcinoma.

Authors:  Rui Liao; Xing-Diao Zhang; Gui-Zhong Li; Ke-Le Qin; Xiong Yan
Journal:  J Gastrointest Oncol       Date:  2020-08

10.  Selective Arterial Embolization of Liver Metastases from Gastrinomas: A Single-Centre Experience.

Authors:  Anneke P J Jilesen; Heinz Josef Klümpen; Olivier R C Busch; T M van Gulik; Krijn P van Lienden; Dirk J Gouma; Els J M Nieveen van Dijkum
Journal:  ISRN Hepatol       Date:  2013-07-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.